Stock News

FDA Risks Sacrificing Its Standards for Speed
Top Picks 2020- Ionis Pharmaceuticals IONS
Biogen Inc. -- Moody's announces completion of a periodic review of ratings of Biogen Inc.
Biogen to buy from Pfizer an asset to develop into potential Alzheimer's, Parkinson's treatments
Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc.
Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy
More drugmakers hike U.S. prices as new year begins

As seen on...